ISHLT/PHA Research Grant in Pulmonary Hypertension Transplantation: Advancing Patient-Centered Outcomes and Access to Care supports researchers studying PH to improve outcomes and access to care.
Funder: International Society for Heart and Lung Transplantation
Due Dates: January 19, 2027 (Application and membership application deadline)
Funding Amounts: One award of up to $100,000 USD over two years
Summary: Supports patient-centered pulmonary hypertension clinical research addressing outcomes, monitoring, access to care, transplantation, and advanced therapies.
Key Information: Applicants must be active ISHLT or PHA members, or submit a completed membership application by the deadline.
This joint initiative of the International Society for Heart and Lung Transplantation (ISHLT) and the Pulmonary Hypertension Association (PHA) supports innovative, patient-centered clinical research in pulmonary hypertension (PH), with relevance to transplantation and advanced therapeutic strategies. It aims to address critical gaps in clinical knowledge and care and improve outcomes across the continuum of PH.
The scope includes PH Groups 1–5, chronic thromboembolic pulmonary hypertension (CTEPH), pediatric populations, PH due to heart and lung diseases, and adults with congenital heart disease. Priorities include outcomes beyond survival, such as quality of life and patient-reported outcomes; monitoring through digital health, remote monitoring, imaging, or related technologies; reducing barriers to specialized PH care; and lung or heart/lung transplantation and advanced PH care.